Opthea Announces Presentation at H.C. Wainwright 2nd Annual : vimarsana.com

MELBOURNE, Australia, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel...

Related Keywords

Australia , Melbourne , Victoria , Sam Martin , Rudi Michelson , Megan Baldwin , Silvana Guerci Lena , Investment In Biotechnology Companies , Company Media Enquiries , Monsoon Communications , Opthea Limited , Nasdaq , Chief Executive Officer , Annual Ophthalmology Virtual Conference , Biotechnology Companies , Media Enquiries , Australian Stock Exchange Opt Ax ,